Presentations Medicenna Therapeutics Corp. - Corporate Presentation Q2 2021 Past Events October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to October 1, 2020 at 12:30 PM EDT Virtual Gravitas Healthcare Investor Day Go to September 30, 2020 at 10:00 AM EDT Medicenna Annual and Special Meeting Go to September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to June 18, 2020 at 1:40 PM EDT Raymond James Human Healthcare Innovation Conference Go to Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Next page next › Last page last »
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to
September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to
